Amanda R McCullough1, Michael M Tunney1, J Stuart Elborn2, Judy M Bradley3, Carmel M Hughes1. 1. Clinical & Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK. 2. Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK. 3. Centre for Health and Rehabilitation Technologies (CHaRT), Institute of Nursing and Health Research, University of Ulster, Jordanstown, UK.
Abstract
BACKGROUND: Adherence to treatment is low in bronchiectasis and is associated with poorer health outcomes. Factors affecting adherence decisions have not been explored in patients with bronchiectasis. OBJECTIVE: We aimed to explore patients' perspectives on adherence, factors affecting adherence decision making and to develop a conceptual model explaining this decision-making process in adults with bronchiectasis. METHODS: Adults with bronchiectasis participated in one-to-one semi-structured interviews. Interviews were audio-recorded, transcribed verbatim and analysed independently by two researchers using thematic analysis. Data from core themes were extracted, categorized into factors affecting adherence decision making and used to develop the conceptual model. RESULTS: Participants' beliefs about treatment, the practical aspects of managing treatment, their trust in health-care professionals and acceptance of disease and treatment were important aspects of treatment adherence. The conceptual model demonstrated that adherence decisions were influenced by participants' individual balance of barriers and motivating factors (treatment-related, disease-related, health-care-related, personal and social factors). CONCLUSION: Adherence decision-making in bronchiectasis is complex, but there is the potential to enhance adherence by understanding patients' specific barriers and motivators to adherence and using this to tailor adherence strategies to individual patients and treatments.
BACKGROUND: Adherence to treatment is low in bronchiectasis and is associated with poorer health outcomes. Factors affecting adherence decisions have not been explored in patients with bronchiectasis. OBJECTIVE: We aimed to explore patients' perspectives on adherence, factors affecting adherence decision making and to develop a conceptual model explaining this decision-making process in adults with bronchiectasis. METHODS: Adults with bronchiectasis participated in one-to-one semi-structured interviews. Interviews were audio-recorded, transcribed verbatim and analysed independently by two researchers using thematic analysis. Data from core themes were extracted, categorized into factors affecting adherence decision making and used to develop the conceptual model. RESULTS: Participants' beliefs about treatment, the practical aspects of managing treatment, their trust in health-care professionals and acceptance of disease and treatment were important aspects of treatment adherence. The conceptual model demonstrated that adherence decisions were influenced by participants' individual balance of barriers and motivating factors (treatment-related, disease-related, health-care-related, personal and social factors). CONCLUSION: Adherence decision-making in bronchiectasis is complex, but there is the potential to enhance adherence by understanding patients' specific barriers and motivators to adherence and using this to tailor adherence strategies to individual patients and treatments.
Authors: Michelle N Eakin; Andrew Bilderback; Michael P Boyle; Peter J Mogayzel; Kristin A Riekert Journal: J Cyst Fibros Date: 2011-03-31 Impact factor: 5.482
Authors: Diana Bilton; Evangelia Daviskas; Sandra D Anderson; John Kolbe; Gregory King; Rob G Stirling; Bruce R Thompson; David Milne; Brett Charlton Journal: Chest Date: 2013-07 Impact factor: 9.410
Authors: Jacqueline Gamble; Michael Stevenson; Elizabeth McClean; Liam G Heaney Journal: Am J Respir Crit Care Med Date: 2009-07-30 Impact factor: 21.405
Authors: Robert Wilson; Tobias Welte; Eva Polverino; Anthony De Soyza; Hugh Greville; Anne O'Donnell; Jeff Alder; Peter Reimnitz; Barbara Hampel Journal: Eur Respir J Date: 2012-09-27 Impact factor: 16.671
Authors: Amanda R McCullough; Michael M Tunney; Alexandra L Quittner; J Stuart Elborn; Judy M Bradley; Carmel M Hughes Journal: BMC Pulm Med Date: 2014-07-01 Impact factor: 3.317
Authors: Amanda R McCullough; Cristín Ryan; Brenda O'Neill; Judy M Bradley; J Stuart Elborn; Carmel M Hughes Journal: BMC Health Serv Res Date: 2015-08-22 Impact factor: 2.655